Certified Global Research Member
Key Questions Answered
- Global Market Outlook
- In-depth analysis of global and regional trends
- Analyze and identify the major players in the market, their market share, key developments, etc.
- To understand the capability of the major players based on products offered, financials, and strategies.
- Identify disrupting products, companies, and trends.
- To identify opportunities in the market.
- Analyze the key challenges in the market.
- Analyze the regional penetration of players, products, and services in the market.
- Comparison of major players’ financial performance.
- Evaluate strategies adopted by major players.
- Recommendations
Why Choose Market Research Future?
- Vigorous research methodologies for specific market.
- Knowledge partners across the globe
- Large network of partner consultants.
- Ever-increasing/ Escalating data base with quarterly monitoring of various markets
- Trusted by fortune 500 companies/startups/ universities/organizations
- Large database of 5000+ markets reports.
- Effective and prompt pre- and post-sales support.
The varicose veins treatment market is anticipated to reach USD 2.2 billion by 2032 at 6% CAGR. The Varicose Veins Treatment Market is affected by several aspects that affect its growth. Varicose veins, a common vascular disorder characterized by swollen and twisted veins, have driven market dynamics via high demand for effective therapies. Global varicose vein prevalence is a major factor. Developing new and more effective therapies drives industry growth.
Varicose vein therapy market dynamics are also influenced by technology. Advanced endovenous laser treatment, radiofrequency ablation, and sclerotherapy improve varicose vein therapies' safety, effectiveness, and patient experience. These technology advances increase treatment choices and boost market development by giving doctors more tools for precise treatments and speedier recovery.
Varicose vein therapy market trends depend on regulatory and approval processes. New medications, medical equipment, and procedures must meet strict safety and effectiveness requirements, and regulatory approvals verify therapeutic efficacy, enabling market access. Pharmaceutical and medical device businesses traverse these regulatory environments to introduce new and better varicose vein therapies, affecting industry dynamics.
Another key market driver is healthcare company and stakeholder competition. To improve their market position and varicose vein treatment portfolios, companies use mergers, acquisitions, and alliances. Companies innovate to stand out by offering new and better treatments. This rivalry drives market evolution by introducing new remedies and satisfying varicose vein patients' different wants.
Varicose vein therapy market dynamics are also influenced by economic variables. Patients' treatment cost and accessibility depend on economic conditions and healthcare spending. Economic downturns may prompt cost-conscious healthcare, affecting market growth. Conversely, a booming economy may raise healthcare investments, raising varicose vein treatment demand.
Market dynamics depend on consumer choices and awareness. Awareness of varicose veins and their influence on quality of life drives timely treatment, generating market demand. Customers' demand for minimally invasive procedures, shorter recovery periods, and outpatient treatments drive varicose veins therapy innovation."
Covered Aspects:
| Report Attribute/Metric | Details |
|---|---|
| Growth Rate | Â Â 6% |
Varicose Veins Treatment Market Highlights:
Global Varicose Veins Treatment Market Overview
The Varicose veins treatments market was valued USD 1.05 billion in 2021 and is projected to reach USD 2.2 billion by 2032 at CAGR of 6% over the forecast period 2023-2032. Swollen, twisted, or deformed veins in the legs are known as varicose veins. They frequently cause pain and discomfort, especially when standing or walking for long periods of time. They can also affect other body areas like the back, buttocks, thighs, and abdomen. Around 30% of adults over the age of 40 have varicose veins. Poor blood flow via the veins causes this disorder. Varicose veins can become painful if left untreated.
Over the last decade, the global market for varicose vein treatments has grown significantly. Factors such as rising varicose vein prevalence, rising need for better treatment options, raising awareness of the condition, and rising healthcare spending are likely to propel the market forward. Furthermore, technological advances in the field of varicose vein treatment have resulted in greater use of minimally invasive techniques. Region-wise, the Americas are expected to dominate the worldwide varicose veins treatment market, with Europe following closely behind.
Varicose Veins Treatment Market Segment Insights
The global varicose veins treatment market has been segmented into type, product type and end user.
Varicose Veins Treatment Type Insights
The market, on the basis of type, has been segmented into endovenous ablation, sclerotherapy, surgical ligation, and stripping and laser ablations.
Varicose Veins Treatment Product Insights
The market, by product, has been segmented into ablation devices, venous closure products and surgical products. By product, ablation devices are expected to hold the largest share owing to their minimal invasive nature and quick recovery. Venous closure products are anticipated to grow at the fastest CAGR due to their ability to treat the disease effectively and rising demand for such products.
Varicose Veins Treatment End-User Insights
The market, by end user, has been segmented into hospitals, specialized clinics, ambulatory surgical centers and others.
Varicose Veins Treatment Regional Insights
The market has been segmented, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The varicose veins treatment market in the Americas has further been segmented into North America and South America, with the North American market divided into the US and Canada.
The European market has been segmented into Western Europe and Eastern Europe. Western Europe has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe.
The varicose veins treatment market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The market in the Middle East & Africa has been segmented into the Middle East and Africa.
Geographically, the Americas is anticipated to dominate the global varicose veins treatment market owing to a rising patient population, increasing healthcare expenditure and growing awareness about the condition. According to a report published by Stanford Medicine in September 2018, 30 million people in the US are affected by varicose veins.
Europe is expected to hold the second largest position in the global market. The market growth in this region is attributed to the well-developed healthcare infrastructure and rising demand for non-invasive treatment options.
The varicose veins treatment market in Asia-Pacific region consists of countries namely China, Japan, Republic of Korea, India, Australia and Rest of Asia-Pacific. The Asia-Pacific region is expected to be fastest growing region owing to the rising prevalence of varicose veins in the region and increasing healthcare expenditure by the government. According to a report published by the World Bank Group, healthcare expenditure of India was 3.89% of the Gross Domestic Product (GDP) in 2015.
Varicose Veins Treatment Market Key players:
- Medtronic
- AngioDynamics
- biolitec AG
- Syneron Medical Ltd.
- Lumenis
- Energist Ltd.
- Eufoton s.r.l.
- Teleflex Incorporated
- Quanta System
- Dornier MedTech
- Scranton Gillette Communications
- Sciton, Inc
- Fotona d.o.o.
- BTG International Ltd.
- Merz North America, Inc.
Varicose Veins Treatment Market Segmentation
Varicose Veins Treatment Type Outlook
- Endovenous Ablation
- Sclerotherapy
- Surgical Ligation
- Stripping
- Laser Ablations
Varicose Veins Treatment Product Outlook
- Ablation Devices
- Venous Closure Products
- Surgical Products
Varicose Veins Treatment End User Outlook
- Hospitals
- Specialized Clinics
- Ambulatory Surgical Centers
- Others
Varicose Veins Treatment Regional Outlook
- Americas
- North America
- US
- Canada
- South America
- North America
- Europe
- Western Europe
- Germany
- France
- Italy
- Spain
- UK
- Rest of Western Europe
- Eastern Europe
- Western Europe
- Asia-Pacific
- Japan
- China
- India
- Australia
- South Korea
- Rest of Asia-Pacific
- Middle East & Africa
- Middle East
- Africa
Recent Development
THERACLION, a cutting-edge business building a scalable robotic platform for non-invasive ultrasound therapy, recently revealed that the SONOVEIN has successfully treated 1000 varicose vein patients. These patients were treated with non-invasive ecotherapy in a number of centers across Europe and Asia, all of which were directed by experts in their fields. The SONOVEIN is the only non-invasive varicose vein ablation therapy device available. This technology eliminates the need for a catheter, chemical injections, or incisions, resulting in no scarring.
With the help of its recent purchase, BD, an American international medical technology business, is expanding its venous therapy range to include treatments for varicose veins. Venclose, a catheter-therapy inventor, is being purchased by the MedTech behemoth. Venclose's treatment involves inserting a radiofrequency ablation catheter into the affected vein and delivering heat to assist shrink and closing the blood vessel. When the procedure is finished, the blood will automatically reroute to surrounding healthy veins.
Intended Audience
- Healthcare Organizations
- Research Laboratories
- Pharmaceutical Companies
- Medical Device Manufacturers
- Research and Development Organizations
- Academic Institutes
Leading companies partner with us for data-driven Insights
Kindly complete the form below to receive a free sample of this Report
Tailored for You
- Dedicated Research on any specifics segment or region.
- Focused Research on specific players in the market.
- Custom Report based only on your requirements.
- Flexibility to add or subtract any chapter in the study.
- Historic data from 2014 and forecasts outlook till 2040.
- Flexibility of providing data/insights in formats (PDF, PPT, Excel).
- Provide cross segmentation in applicable scenario/markets.
